Chengdu Kanghua Biological Products Co., Ltd.
SZSE:300841.SZ
64.68 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 319.294 | 425.892 | 309.934 | 583.479 | 355.616 | 356.325 | 278.114 | 392.176 | 394.778 | 393.035 | 266.736 | 503.791 | 228.248 | 323.26 | 237.15 | 213.6 | 370.122 | 297.815 | 157.099 | 260.37 | 23.428 | 140.335 | 130.503 | 130.368 |
| Cost of Revenue
| 20.302 | 51.825 | 12.932 | 50.632 | 22.64 | 23.161 | 17.959 | 26.319 | 26.672 | 24.635 | 15.509 | 23.527 | 16.62 | 27.796 | 15.807 | 24.081 | 17.917 | 14.485 | 6.36 | 11.726 | 1.372 | 11.237 | 8.014 | 7.859 |
| Gross Profit
| 298.992 | 374.067 | 297.001 | 532.847 | 332.976 | 333.164 | 260.155 | 365.858 | 368.106 | 368.399 | 251.227 | 480.264 | 211.628 | 295.464 | 221.343 | 189.519 | 352.205 | 283.33 | 150.739 | 248.644 | 22.056 | 129.098 | 122.489 | 122.509 |
| Gross Profit Ratio
| 0.936 | 0.878 | 0.958 | 0.913 | 0.936 | 0.935 | 0.935 | 0.933 | 0.932 | 0.937 | 0.942 | 0.953 | 0.927 | 0.914 | 0.933 | 0.887 | 0.952 | 0.951 | 0.96 | 0.955 | 0.941 | 0.92 | 0.939 | 0.94 |
| Reseach & Development Expenses
| 27.881 | 18.466 | 25.825 | 62.011 | 80.114 | 57.156 | 48.658 | 52.211 | 59.54 | 47.179 | 21.011 | 33.104 | 11.341 | 17.677 | 16.753 | 20.886 | 16.801 | 18.009 | 2.558 | 13.466 | 3.019 | 3.324 | 2.977 | 11.348 |
| General & Administrative Expenses
| 61.478 | -5.371 | 24.974 | -40.952 | 55.808 | -11.732 | 22.181 | -33.052 | 44.057 | -5.233 | 19.139 | -31.94 | 46.463 | -7.574 | 24.001 | -18.316 | 17.991 | 5.567 | 12.811 | -11.634 | 8.162 | 13.404 | 19.3 | -7.114 |
| Selling & Marketing Expenses
| 153.819 | 135.153 | 71.895 | 225.183 | 95.155 | 96.718 | 78.388 | 170.605 | 104.149 | 84.683 | 68.684 | 193.955 | 63.473 | 89.974 | 64.669 | 77.02 | 132.462 | 102.731 | 58.831 | 104.092 | 5.801 | 51.259 | 55.886 | 61.936 |
| SG&A
| 215.297 | 176.732 | 102.425 | 261.155 | 150.962 | 84.986 | 100.569 | 137.552 | 148.206 | 79.45 | 87.822 | 162.015 | 109.935 | 82.4 | 88.67 | 58.704 | 150.453 | 108.298 | 71.642 | 92.457 | 13.963 | 64.663 | 75.186 | 54.822 |
| Other Expenses
| -50.704 | 0.045 | 0.094 | -2.923 | -15.712 | 15.366 | -0.149 | 51.248 | -9.472 | 8.409 | -0 | 269.298 | 0.326 | -0.474 | -0.004 | -0.651 | -0.405 | -0.008 | -0.058 | -0.003 | -0.058 | 0.005 | -0.015 | 0.027 |
| Operating Expenses
| 192.473 | 195.154 | 128.156 | 326.09 | 206.101 | 172.392 | 150.099 | 245.782 | 183.283 | 150.299 | 108.756 | 238.507 | 97.985 | 124.75 | 106.266 | 113.832 | 167.758 | 142.13 | 74.404 | 128.117 | 17.022 | 68.248 | 78.6 | 80.983 |
| Operating Income
| 111.237 | 178.913 | 168.845 | 206.757 | 130.404 | 161.084 | 117.038 | 134.564 | 189.295 | 205.508 | 156.134 | 264.848 | 352.21 | 179.732 | 118.968 | 78.272 | 190.529 | 139.019 | 77.239 | 116.323 | 5.019 | 60.239 | 41.823 | 19.821 |
| Operating Income Ratio
| 0.348 | 0.42 | 0.545 | 0.354 | 0.367 | 0.452 | 0.421 | 0.343 | 0.479 | 0.523 | 0.585 | 0.526 | 1.543 | 0.556 | 0.502 | 0.366 | 0.515 | 0.467 | 0.492 | 0.447 | 0.214 | 0.429 | 0.32 | 0.152 |
| Total Other Income Expenses Net
| -0.103 | 0.245 | 3.299 | -40.795 | -0.268 | -0.078 | -0.149 | -0.646 | 0.061 | -1.124 | -0 | -0.026 | 0.326 | -0.474 | -0.004 | -0.651 | -0.405 | -0.008 | -0.058 | -0.003 | -0.058 | 0.005 | -0.015 | 0.027 |
| Income Before Tax
| 111.135 | 179.158 | 172.144 | 165.962 | 130.136 | 161.007 | 116.889 | 133.918 | 189.356 | 204.384 | 156.134 | 264.822 | 352.536 | 179.258 | 118.964 | 77.621 | 190.125 | 139.011 | 77.181 | 116.32 | 4.961 | 60.244 | 41.808 | 19.848 |
| Income Before Tax Ratio
| 0.348 | 0.421 | 0.555 | 0.284 | 0.366 | 0.452 | 0.42 | 0.341 | 0.48 | 0.52 | 0.585 | 0.526 | 1.545 | 0.555 | 0.502 | 0.363 | 0.514 | 0.467 | 0.491 | 0.447 | 0.212 | 0.429 | 0.32 | 0.152 |
| Income Tax Expense
| 11.787 | 22.07 | 22.677 | 25.684 | 9.403 | 17.992 | 11.698 | 19.165 | 21.72 | 23.985 | 20.857 | 18.705 | 21.344 | 27.588 | 18.464 | 13.24 | 29.151 | 21.196 | 12.306 | 18.101 | 1.266 | 11.003 | 6.276 | 7.523 |
| Net Income
| 99.347 | 157.088 | 149.467 | 140.278 | 120.733 | 143.014 | 105.191 | 114.753 | 167.637 | 180.399 | 135.277 | 246.117 | 331.191 | 151.67 | 100.5 | 64.381 | 160.974 | 117.816 | 64.876 | 98.22 | 3.695 | 49.241 | 35.531 | 12.325 |
| Net Income Ratio
| 0.311 | 0.369 | 0.482 | 0.24 | 0.34 | 0.401 | 0.378 | 0.293 | 0.425 | 0.459 | 0.507 | 0.489 | 1.451 | 0.469 | 0.424 | 0.301 | 0.435 | 0.396 | 0.413 | 0.377 | 0.158 | 0.351 | 0.272 | 0.095 |
| EPS
| 0.76 | 1.19 | 1.12 | 1.04 | 0.9 | 1.07 | 0.79 | 0.86 | 1.25 | 1.35 | 1.01 | 1.82 | 2.45 | 1.12 | 0.74 | 0.48 | 1.19 | 1.16 | 0.64 | 0.97 | 0.037 | 0.49 | 0.35 | 0.24 |
| EPS Diluted
| 0.76 | 1.19 | 1.12 | 1.02 | 0.9 | 1.07 | 0.79 | 0.86 | 1.25 | 1.35 | 1.01 | 1.82 | 2.45 | 1.12 | 0.74 | 0.48 | 1.19 | 1.16 | 0.64 | 0.97 | 0.037 | 0.49 | 0.35 | 0.24 |
| EBITDA
| 112.433 | 203.218 | 178.493 | 225.504 | 114.442 | 179.515 | 112.653 | 173.663 | 178.258 | 235.067 | 147.832 | 516.445 | 119.626 | 182.02 | 118.104 | 82.68 | 183.298 | 142.639 | 76.854 | 120.751 | 5.2 | 61.045 | 43.94 | 43.984 |
| EBITDA Ratio
| 0.352 | 0.477 | 0.576 | 0.386 | 0.322 | 0.504 | 0.405 | 0.443 | 0.452 | 0.598 | 0.554 | 1.025 | 0.524 | 0.563 | 0.498 | 0.387 | 0.495 | 0.479 | 0.489 | 0.464 | 0.222 | 0.435 | 0.337 | 0.337 |